Unicycive Therapeutics, Inc.

Yield per half year: +48.41%
Dividend yield: 0%
Sector: Healthcare

Fair price Unicycive Therapeutics, Inc.

Current price
6.07 $
Average price
7.69 $ +26.75%

Price based on EPS
10.23 $ +68.48%
Discount price Net Income
5.16 $ -14.97%
5/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 10.23 $
Current price = 6.07 $ (difference = +68.48%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = βˆ‘ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -23.85 $
Current price = 6.07 $ (difference = -492.95%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = βˆ‘ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -19.47 $
Current price = 6.07 $ (difference = -420.7%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription